Team

Right now, far too many patients are desperate for breakthrough treatments across different types of cancers and rare diseases. Onena Medicines rapidly discovers lifesaving drug treatments using artificial intelligence combined with unique screening technologies. We aim to deliver a pipeline of first-in-class DSIP neutralizing molecules to the clinic over the coming years.

Onena Medicines is a spinout company from Stanford University in California with a headquarters in Basel, Switzerland and an R&D center in San Sebastian, Spain. We’ve built a culture that draws strength from diversity. We are achieving our Silicon Valley vision of bringing forward cutting edge treatments using Swiss execution and European thoughtfulness.

That´s why we named our company Onena Medicines: translated from the ancient language of Euskera to mean ¨the best medicines”. That’s what all patients deserve.